Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-acinetobacter baumannii complex from various clinical specimens

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6267-6271

  Tien, Ni ^a,b,c   You, Bang Jau ^c   Chang, Hui Lan ^a   Lin, Hsiu Shen ^a   Lee, Chin Yi ^a   Chung, Tung Ching ^b   Lu, Jang Jih ^c,d   Chang, Chao Chin ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RIBOSOME RNA; RNA 16S; RNA 23S; SPACER DNA; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCITES FLUID; BACTERIUM ISOLATE; CATHETER; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; NONHUMAN; PRIORITY JOURNAL; PUS; SPUTUM; URINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TAIWAN;

EID: 84869212657     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01304-12     Document Type: Article

References (43)

1. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Bouvet PJM, Grimont PAD. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36:228-240.
3. Chang HC, et al. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43:1632-1639.
4. Chang HL, et al. 2009. Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan. Infect. Control. Hosp. Epidemiol. 30:34-38.
5. Dijkshoorn L, et al. 1993. Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J. Clin. Microbiol. 31:702-705.
6. Dolzani L, Tonin E, Lagatolla C, Prandin L, Monti-Bragadin C. 1995. Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic-spacer sequences. J. Clin. Microbiol. 33:1108-1113.
7. Dueñas Díez AI, et al. 2004. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Int. J. Antimicrob. Agents 23:487-493.
8. Fournier PE, Richet H. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42:692-699.
9. GarcíA-Arata MI, Gerner-Smidt P, Ibrahim A. 1997. PCR-amplified 16S and 23S rDNA restriction analysis for the identification of Acinetobacter strains at the DNA group level. Res. Microbiol. 148:777-784.
10. Gerner-Smidt P, Tjernberg I, Ursing J. 1991. Reliability of phenotypic tests for identification of Acinetobacter species. J. Clin. Microbiol. 29:277-282.
11. Harald S, Rainer B, Andrea S, Gerhard P. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agent Chemother. 37:750-753.
12. Ho M, et al. 1999. 1998 Surveillance of antibiotic resistance in Taiwan. J. Microbiol. Immunol. Infect. 32:239-249.
13. Horrevorts A, et al. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572.
14. Houang ET, et al. 2003. Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob. Agents Chemother. 47:1472-1475.
15. Hsueh PR, Liu CY, Luh KT. 2002. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8:132-137.
16. Hsueh PR, et al. 2001. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb. Drug Resist. 7:373-382.
17. Huang YT, Hsueh PR. 2008. Antimicrobial drug resistance in Taiwan. Int. J. Antimicrob. Agents. 32:S174-S178.
18. Idzenga D, Schouten MA, van Zanten AR. 2006. Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit. J. Hosp. Infect. 63:485-487.
19. Janssen P, et al. 1997. Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int. J. Syst. Bacteriol. 47:1179-1187.
20. Jean SS, Hsueh PR. 2011. Antimicrobial drug resistance in Taiwan. J. Formos. Med. Assoc. 110:4-13.
21. Jean SS, et al. 2009. Nationwide surveillance of antimicrobial resistance among non-fermentative gram negative bacteria in intensive care units in Taiwan: SMART programmed data 2005. Int. J. Antimicrob. Agents. 33:266-271.
22. Ko WC, et al. 2008. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J. Clin. Microbiol. 46:2052-2059.
23. Lee Y, et al. 2011. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J. Antimicrob. Chemother. 66:66-72.
24. Lee YC, et al. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J. Antimicrob. Chemother. 66:1839-1846.
25. Lim YM, Shin KS, Kim J. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905.
26. Lin MF, et al. 2009. Clinical features and molecular epidemiology of multidrug-resistant Acinetobacter calcoaceticus-A baumannii complex in a regional teaching hospital in Taiwan. Am. J. Infect. Control. 37:e1-e3.
27. Lõivukene K, Sepp E, Adamson V, Mitt Kallandi PU, Otter K, Naaber P. 2006. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care unit on comparison with European data. Scand. J. Infect. Dis. 38:1001-1008.
28. Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263.
29. Montefour K, et al. 2008. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit. Care. Nurse 28:15-25.
30. Murray CK, Hospenthal DR. 2005. Treatment of multidrug resistant Acinetobacter. Curr. Opin. Infect. Dis. 18:502-506.
31. Nemec A, Janda L, Melter O, Dijkshoorn L. 1999. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J. Med. Microbiol. 48:287-296.
32. Paul CS, Maryan ID, Dannie GH. 2007. Acinetobacter, Alcaligenes, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods, p 770-802. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
33. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
34. Piatti G, Mannini A, Balistreri M, Schito AM. 2008. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J. Clin. Microbiol. 46:480-487.
35. Quale J, Bratu S, Landman D, Heddurshetti R. 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis. 37:214-220.
36. Spence RP, van der Reijden TJ, Dijkshoorn L, Towner KJ. 2004. Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant Northern European genotypes by amplified-fragment length polymorphism analysis. J. Clin. Microbiol. 42:832-834.
37. Starcic Erjavec M, Rijavec M, Krizan-Hergouth V, Fruth A, Zgur-Bertok D. 2007. Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential. Int. J. Antimicrob. Agents 30:436-442.
38. Unal S, Garcia-Rodriguez JA. 2005. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004. Diagn. Microbiol. Infect. Dis. 53:265-271.
39. van Dessel H, et al. 2002. Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J. Hosp. Infect. 51:89-95.
40. Vaneechoutte M, et al. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11-15.
41. Van Looveren M, Goossens H, ARPAC Steering Group. 2004. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 10:684-704.
42. Villers D, et al. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:182-189.
43. Wisplinghoff H, et al. 2008. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin. Microbiol. Infect. 214:708-715.